BARCLAYS PLC enters AEON BIOPHARMA, INC. with 702.64K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 3/31/2023ACC: 0000312069-23-000065
702.64K
Baseline shares
0.00
Direct ownership
0 positions
152.39K
Derivative underlying
1 instrument
1
Security positions
702.64K indirect
Non-Derivative Holdings1
Class A common stock, par value $0.0001 per share
IndirectShares owned702.64K
Total
702.64K indirect702.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A common stock, par value $0.0001 per share | 702.64K | Indirect |
| Total | 702.64K | 702.64K indirect |
Derivative Holdings1
Redeemable Warrants
IndirectUnderlying security
Class A Ordinary Share
Underlying shares
152.39K
Shares owned
N/A
Exercise price
11.5
Expiration
—
Exercise window
—
Total
Underlying
152.39K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Redeemable Warrants Indirect | Class A Ordinary Share | 11.5 | — | — | 152.39K | N/A |
| Total | 152.39K | 0.00 | ||||